A detailed history of Cresset Asset Management, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 3,542 shares of ITCI stock, worth $308,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,542
Previous 3,575 0.92%
Holding current value
$308,012
Previous $244,000 5.74%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.99 - $80.84 $2,243 - $2,667
-33 Reduced 0.92%
3,542 $258,000
Q2 2024

Aug 14, 2024

SELL
$64.76 - $79.84 $6,216 - $7,664
-96 Reduced 2.62%
3,575 $244,000
Q1 2024

May 15, 2024

BUY
$64.37 - $75.65 $5,535 - $6,505
86 Added 2.4%
3,671 $254,000
Q4 2023

Feb 14, 2024

SELL
$46.37 - $73.65 $11,963 - $19,001
-258 Reduced 6.71%
3,585 $256,000
Q3 2023

Nov 14, 2023

BUY
$52.09 - $64.1 $200,181 - $246,336
3,843 New
3,843 $200,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.21B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.